![Min-Chul Park](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Min-Chul Park
Director/Miembro de la Junta en ZYVERSA THERAPEUTICS, INC. .
Fortuna: - $ al 30/06/2024
Cargos activos de Min-Chul Park
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ZYVERSA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/12/2022 | - |
Independent Dir/Board Member | 01/12/2022 | - | |
ZyVersa Therapeutics Operating, Inc.
![]() ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Director/Miembro de la Junta | - | - |
Inje University | Corporate Officer/Principal | - | - |
Historial de carrera de Min-Chul Park
Antiguos cargos conocidos de Min-Chul Park.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CURE BIO Co., Ltd.
![]() CURE BIO Co., Ltd. BiotechnologyHealth Technology CURE BIO Co., Ltd. ENGAGES in the research and development of therapeutic and diagnostic products through the use of aminoacyl tRNA synthetase. The company was founded in 2002 and is headquartered in Seoul, South Korea. | Director/Miembro de la Junta | 01/10/2020 | 01/04/2022 |
Director Ejecutivo | 01/10/2020 | 01/04/2022 | |
Neomics Co., Ltd.
![]() Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Neomics Co., Ltd. develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer. It provides services of custom antibody and protein production and offers antibody groups including in-house antibodies from aminoacyl-tRNA synthesize. The company was founded by Chi Uk In in 2005 and is headquartered in Seoul, South Korea. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - |
Formación de Min-Chul Park.
Seoul National University | Doctorate Degree |
Estadísticas
Internacional
Corea del Sur | 5 |
Estados Unidos | 3 |
Operativa
Director/Board Member | 5 |
Chief Executive Officer | 3 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ZYVERSA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Neomics Co., Ltd.
![]() Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Neomics Co., Ltd. develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer. It provides services of custom antibody and protein production and offers antibody groups including in-house antibodies from aminoacyl-tRNA synthesize. The company was founded by Chi Uk In in 2005 and is headquartered in Seoul, South Korea. | Health Technology |
ZyVersa Therapeutics Operating, Inc.
![]() ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
CURE BIO Co., Ltd.
![]() CURE BIO Co., Ltd. BiotechnologyHealth Technology CURE BIO Co., Ltd. ENGAGES in the research and development of therapeutic and diagnostic products through the use of aminoacyl tRNA synthetase. The company was founded in 2002 and is headquartered in Seoul, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Min-Chul Park
- Experiencia